In the week of September 14, 2026, the RCM landscape reveals a clear trend: investors are increasingly focused on solutions that address systemic inefficiencies in healthcare. Amperos, backed by Bessemer Venture Partners, is at the forefront of tackling the staggering $260 billion denial management challenge, highlighting a growing recognition of the financial burdens that unresolved claims impose on healthcare systems. This week's deals underscore a decisive shift towards capital allocation aimed at enhancing operational efficiency and revenue recovery in the sector.
Claim Denials & Denial Management (Google News)
Amperos has secured funding from Bessemer Venture Partners to address the healthcare industry's significant denial management issue, which costs over $260 billion annually. The specific amount of the funding has not been disclosed. This investment highlights the growing demand for innovative solutions in revenue cycle management (RCM) to improve efficiency and reduce financial losses from claim denials.
Source →Every deal, every week
Subscribe to the RevCycleAI newsletter. Free weekly RCM intelligence — deals, payer moves, and vendor deep dives.
Subscribe Free →